Table 2. Changes in Between Days (Pre-Post Values) in Cyclistsa.
| Groups | A | B | Diff. AB (95% CI) | PAB-Value | C | D | Diff.CD (95% CI) | PCD-Value |
|---|---|---|---|---|---|---|---|---|
| a. hs-cRP (mg/d) | ||||||||
| Soy | 5.85 ± 1.7 | 4.79 ± 1.4 | 1.06 ± 0.5 (0.7 1.4) | < 0.001 | 1.68 ± 0.7 | 1.41 ± 0.9 | 0.28 ± 0.7 (0.2 0.8) | 0.26 |
| Placebo | 5.35 ± 0.7 | 5.37 ± 0.7 | -0.01 ± 0.07 (0.03 0.07) | 0.47 | 1.50 ± 0.8 | 1.49 ± 0.8 | 0.01 ± 0.06 (0.030.05) | 0.71 |
| b. CK (IU/L) | ||||||||
| Soy | 315.86 ± 59.5 | 239.09 ± 70.2 | 76.77 ± 19.1 (63.1 90.4) | < 0.001 | 115.15 ± 31.1 | 111.28 ± 42.7 | 3.87 ± 33.8 (20.3 28.1) | 0.72 |
| Placebo | 241.41 ± 35.7 | 242.98 ± 31.6 | -1.56 ± 7.1 (3.4 6.6) | 0.49 | 46.64 ± 21.8 | 45.72 ± 22.1 | 0.92 ± 4.9 (2.5 4.4) | 0.56 |
| c. MPO (ng/L) | ||||||||
| Soy | 4.44 ± 1.5 | 3.12 ± 1.6 | 1.32 ± 0.7 (0.8 1.8) | < 0.001 | 2.21 ± 0.6 | 2.19 ± 0.7 | 0.02 ± 1.1 (0.80 0.82) | 0.97 |
| Placebo | 5.04 ± 1.4 | 5.07 ± 1.4 | -0.03 ± 0.04 (0.0 0.06) | 0.05 | 1.87 ± 0.5 | 1.88 ± 0.5 | -0.01 ± 0.07 (0.04 0.05) | 0.79 |
| d. ISOR EXT (Nm) | ||||||||
| Soy | 38.6 ± 11.3 | 36.6 ± 13.8 | 2.0 ± 4.4 (1.1 5.1) | 0.18 | 15.2 ± 2.8 | 15.9 ± 4.1 | -0.7 ± 4.8 (2.7 4.1) | 0.66 |
| Placebo | 22.2 ± 6.0 | 24.9 ± 6.9 | -2.7 ± 9.6 (4.2 9.6) | 0.39 | 11.3 ± 2.7 | 14.2 ± 10.7 | -2.9 ± 9.1 (3.6 9.4) | 0.34 |
| e. ISOR FLEX (Nm) | ||||||||
| Soy | 38.2 ± 10.0 | 35.7 ± 9.7 | 2.5 ± 4.9 (1.0 6.0) | 0.14 | 14.3 ± 3.4 | 14.9 ± 5.0 | -0.6 ± 3.7 (2.1 3.2) | 0.62 |
| Placebo | 17.6 ± 4.9 | 16.5 ± 7.2 | 1.1 ± 3.8 (1.6 3.8) | 0.38 | 11.3 ± 3.0 | 10.3 ± 4.2 | 1.0 ± 2.1 (0.5 2.5) | 0.16 |
| f. ISOL EXT (Nm) | ||||||||
| Soy | 34.2 ± 9.7 | 30.4 ± 10.5 | 3.8 ± 4.8 (0.3 7.2) | <0.05 | 10.3 ± 11.0 | 10.5 ± 10.6 | -0.2 ± 5.1 (3.4 3.8) | 0.90 |
| Placebo | 20.6 ± 4.6 | 23.5 ± 6.8 | -2.9 ± 5.7 (1.2 6.9) | 0.14 | 14.2 ± 1.9 | 15.7 ± 6.7 | -1.5 ± 7.1 (3.6 6.6) | 0.52 |
| g. ISOL FLEX (Nm) | ||||||||
| Soy | 40 ± 11.9 | 37.7 ± 11 | 2.3 ± 4.7 (1.1 5.7) | 0.15 | 13.6 ± 4.1 | 15.0 ± 5.4 | -1.4 ± 3.6 (1.2 3.9) | 0.24 |
| Placebo | 13.8 ± 4.3 | 13.8 ± 16.4 | 0.0 ± 16.2, (-11.5 11.5) | 1.00 | 15.7 ± 3.6 | 15.0 ± 6 | -0.7 ± 4.9 (3.4 3.6) | <0.001 |
| h. VO 2 (mL/kg.minute -1 ) | ||||||||
| Soy | 2.1 ± 0.8 | 2.5 ± 0.9 | -0.4 ± 0.7 (0.1 0.9) | 0.10 | 1.2 ± 0.63 | 1.4 ± 0.7 | -0.2 ± 0.6 (0.2 0.6) | 0.34 |
| Placebo | 2.2 ± 0.8 | 2.4 ± 0.5 | -0.2 ± 0.91 (0.4 0.8) | 0.50 | 1.2 ± 0.42 | 0.7 ± 1.1 | 0.5 ± 1.2 (0.4 1.4) | 0.24 |
| i. HR (beats/minute) | ||||||||
| Soy | 17.4 ± 3.2 | 15.1 ± 2.5 | 2.3 ± 2.7 (0.3 4.3) | 0.02 | 7.6 ± 2.0 | 8.6 ± 2.2 | -1.0 ± 2.9 (1.1 3.1) | 0.30 |
| Placebo | 18.6 ± 3.6 | 18.8 ± 4.5 | -0.2 ± 2.7 (1.8 2.2) | 0.82 | 9.0 ± 4.4 | 11.8 ± 4.7 | -2.8 ± 6.0 (1.5 7.1) | 0.17 |
| j. VAS | ||||||||
| Soy | - | - | - | - | 1.3 ± 0.9 | 1.5 ± 0.97 | -0.2 ± 0.42 (0.1 0.5) | 0.16 |
| Placebo | - | - | - | - | 0.9 ± 0.56 | 0.8 ± 0.63 | 0.1 ± 0.87 (0.5 0.7) | 0.72 |
aA, Degree of change in pre supplementation mean ± SD values from day 1 to day 2; B, degree of change in post supplementation mean ± SD values from day 1 to day 2; Diff.AB, difference between pre and post supplementation values; C, degree of change in pre supplementation mean ± SD values from day 2 to day 3; D, degree of change in post supplementation mean ± SD values from day 2 to day 3; Diff.CD, difference between pre and post supplementation values; hs-cRP, highly sensitive C reactive protein; CK-creatine kinase; MPO, myeloperoxidase; Iso R/L Ext/Flex, isometric right/left knee extension/ flexion; VO2, maximum oxygen consumption; HR, heart rate; VAS, visual analog scale; CI, confidence interval; SD, standard deviation; P, probability value; P ≤ 0.001(S), P ≤ 0.01(S), P ≤ 0.05(S).